Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binqing Fu

Showing results (71-80 of 72) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 72 results.
Nature Communications|August 9, 2020
Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine stormChuang Guo, Bin Li, Huan Ma, et al.
Frontiers of Medicine|March 9, 2021
Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trialDongsheng Wang, Binqing Fu, Zhen Peng, et al.
Pageof 8

Showing results (71-80 of 72) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 72 results.
Nature Communications|August 9, 2020
Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine stormChuang Guo, Bin Li, Huan Ma, et al.
Frontiers of Medicine|March 9, 2021
Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trialDongsheng Wang, Binqing Fu, Zhen Peng, et al.
Pageof 8